Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reolysin with Docetaxel or Pemetrexed in Advanced NSCLC
NCT01708993Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Dec 2012
- Primary completion
- Jan 2016
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pelareorep in non-small cell lung cancer (NSCLC), sponsored by Canadian Cancer Trials Group. Started Dec 2012; status: completed.
02
Drugs
pelareorep
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01708993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01708993.